Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Subhash Thuluva, Vikram Paradkar, Ramesh Matur, Kishore Turaga & Subba Reddy GV. (2022) A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E’s Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Thomas J. Griffin$suffix/text()$suffix/text(), Ann Thanawastien, Robert T. Cartee, John J. Mekalanos & Kevin P. Killeen. (2019) In vitro characterization and preclinical immunogenicity of Typhax, a typhoid fever protein capsular matrix vaccine candidate. Human Vaccines & Immunotherapeutics 15:6, pages 1310-1316.
Read now
Read now
Aadil Hussain Bhat, Sudipa Maity, Kuldeep Giri & Kiran Ambatipudi. (2019) Protein glycosylation: Sweet or bitter for bacterial pathogens?. Critical Reviews in Microbiology 45:1, pages 82-102.
Read now
Read now
Erman Tritama, Catur Riani, Indra Rudiansyah, Arip Hidayat, Siti Azizah Kharisnaeni & Debbie Sofie Retnoningrum. (2018) Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines. Human Vaccines & Immunotherapeutics 14:6, pages 1524-1529.
Read now
Read now
Jane N Zuckerman, Christoph Hatz & Anu Kantele. (2017) Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines. Expert Review of Vaccines 16:10, pages 1029-1043.
Read now
Read now
Vittal Mogasale, Enusa Ramani, Il Yeon Park & Jung Seok Lee. (2017) A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions. Human Vaccines & Immunotherapeutics 13:9, pages 2017-2024.
Read now
Read now
Nicola Principi & Susanna Esposito. (2016) Preventing invasive salmonellosis in children through vaccination. Expert Review of Vaccines 15:7, pages 897-905.
Read now
Read now
Calman A MacLennan, Laura B Martin & Francesca Micoli. (2014) Vaccines against invasive Salmonella disease. Human Vaccines & Immunotherapeutics 10:6, pages 1478-1493.
Read now
Read now
Subhash C Arya & Nirmala Agarwal. (2014) Comment on: development of Vi conjugate – a new generation of typhoid vaccine. Expert Review of Vaccines 13:4, pages 453-454.
Read now
Read now
Articles from other publishers (78)
Federica Compostella, Laura Morelli & Luigi Lay. 2023. Carbohydrate‐Based Therapeutics. Carbohydrate‐Based Therapeutics
1
56
.
Davide Oldrini, Roberta Di Benedetto, Martina Carducci, Daniele De Simone, Luisa Massai, Renzo Alfini, Barbara Galli, Brunella Brunelli, Amanda Przedpelski, Joseph T. Barbieri, Omar Rossi, Carlo Giannelli, Rino Rappuoli, Francesco Berti & Francesca Micoli. (2023) Testing a Recombinant Form of Tetanus Toxoid as a Carrier Protein for Glycoconjugate Vaccines. Vaccines 11:12, pages 1770.
Crossref
Crossref
Natasha R Gloeck, Trudy Leong, Chinwe Juliana Iwu-Jaja, Patrick de Marie Katoto, Tamara Kredo & Charles S Wiysonge. (2023) Typhoid conjugate vaccines for preventing typhoid fever (enteric fever). Cochrane Database of Systematic Reviews 2023:6.
Crossref
Crossref
Calman A MacLennan, Jeffrey Stanaway, Stephanie Grow, Kirsten Vannice & A Duncan Steele. (2023)
Salmonella
Combination Vaccines: Moving Beyond Typhoid
. Open Forum Infectious Diseases 10:Supplement_1, pages S58-S66.
Crossref
Crossref
Siân E. Jossi, Melissa Arcuri, Areej Alshayea, Ruby R. Persaud, Edith Marcial-Juárez, Elena Palmieri, Roberta Di Benedetto, Marisol Pérez-Toledo, Jamie Pillaye, Will M. Channell, Anna E. Schager, Rachel E. Lamerton, Charlotte N. Cook, Margaret Goodall, Takeshi Haneda, Andreas J. Bäumler, Lucy H. Jackson-Jones, Kai-Michael Toellner, Calman A. MacLennan, Ian R. Henderson, Francesca Micoli & Adam F. Cunningham. (2023) Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses. Frontiers in Immunology 14.
Crossref
Crossref
Myron M. Levine, Kathleen Maletic Neuzil & Sir Andrew J. Pollard. 2023. Plotkin's Vaccines. Plotkin's Vaccines
1177
1214.e11
.
Josefina Cadorna Carlos, Birkneh Tilahun Tadesse, Charissa Borja-Tabora, Edison Alberto, Michelle C. Ylade, Arijit Sil, Deok Ryun Kim, Hyeon Seon Ahn, Jae Seung Yang, Ji Yeon Lee, Min Soo Kim, Jiwook Park, Soo-Young Kwon, Hun Kim, Seon-Young Yang, Ji-hwa Ryu, Hokeun Park, Jong-hoon Shin, Yoonyeong Lee, Jerome H. Kim, Zenaida Reynoso Mojares, T. Anh Wartel & Sushant Sahastrabuddhe. (2022) A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age. The Lancet Regional Health - Western Pacific 24, pages 100484.
Crossref
Crossref
Ganesh Kumar Rai, Tarun Saluja, Shipra Chaudhary, Dipesh Tamrakar, Piush Kanodia, Bishnu Rath Giri, Rajeev Shrestha, Surendra Uranw, Deok Ryun Kim, Jae Seung Yang, Il-Yeon Park, Seung-Eun Kyung, Sridhar Vemula, Jagadeesh Reddy E, Bomi Kim, Birendra Prasad Gupta, Sue Kyoung Jo, Ji Hwa Ryu, Ho Keun Park, Jong Hoon Shin, Yoonyeong Lee, Hun Kim, Jerome H Kim, Zenaida Reynoso Mojares, T Anh Wartel & Sushant Sahastrabuddhe. (2022) Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial. The Lancet Infectious Diseases 22:4, pages 529-540.
Crossref
Crossref
Rupal Ojha & Vijay Kumar Prajapati. (2021) Cognizance of posttranslational modifications in vaccines: A way to enhanced immunogenicity. Journal of Cellular Physiology 236:12, pages 8020-8034.
Crossref
Crossref
Abdulmaleek Idanesimhe Sado & Aduke Oluwambe Sado. 2021. Salmonella spp. - A Global Challenge. Salmonella spp. - A Global Challenge.
Christophe Neyra, Didier Clénet, Marcia Bright, Richard Kensinger & Steven Hauser. (2021) Predictive modeling for assessing the long-term thermal stability of a new fully-liquid quadrivalent meningococcal tetanus toxoid conjugated vaccine. International Journal of Pharmaceutics 609, pages 121143.
Crossref
Crossref
Krishna Mohan Vadrevu, Dugyala Raju, Sandhya Rani, Siddharth Reddy, Vamshi Sarangi, Raches Ella, Bhuvaneswara Javvaji, Niranjana S. Mahantshetty, Sudhakar Battu & Myron M. Levine. (2021) Persisting antibody responses to Vi polysaccharide–tetanus toxoid conjugate (Typbar TCV®) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination. Vaccine 39:45, pages 6682-6690.
Crossref
Crossref
Michael Kowarik, Michael Wetter, Micha A. Haeuptle, Martin Braun, Michael Steffen, Stefan Kemmler, Neil Ravenscroft, Gianluigi De Benedetto, Matthias Zuppiger, Dominique Sirena, Paola Cescutti & Michael Wacker. (2021) The development and characterization of an E. coli O25B bioconjugate vaccine. Glycoconjugate Journal 38:4, pages 421-435.
Crossref
Crossref
M. V. Abramtseva, E. O. Nemanova, N. S. Alekhina & T. I. Nemirovskaya. (2021) Typhoid vaccines. Historical aspects of typhoid vaccine development, and currently available products. BIOpreparations. Prevention, Diagnosis, Treatment 21:2, pages 85-96.
Crossref
Crossref
David Galloway & Mitchell B. Cohen. 2021. Pediatric Gastrointestinal and Liver Disease. Pediatric Gastrointestinal and Liver Disease
398
415.e5
.
Barbara Richichi, Giuseppe Stefanetti, Giacomo Biagiotti & Luigi Lay. 2021. Comprehensive Glycoscience. Comprehensive Glycoscience
676
705
.
Natalie Prevatt & Ron H. Behrens. 2021. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations
261
279
.
Punit Kumar, Sunita, Kashyap Kumar Dubey & Pratyoosh Shukla. 2021. Vaccine Delivery Technology. Vaccine Delivery Technology
249
266
.
Maria Rosario Capeding, Arijit Sil, Birkneh Tilahun Tadesse, Tarun Saluja, Samuel Teshome, Edison Alberto, Deok Ryun Kim, Eun Lyeong Park, Ju Yeon Park, Jae Seung Yang, Suchada Chinaworapong, Jiwook Park, Sue-Kyoung Jo, Yun Chon, Seon-Young Yang, Ji Hwa Ryu, Inho Cheong, Kyu-Young Shim, Yoonyeong Lee, Hun Kim, Julia A. Lynch, Jerome H. Kim, Jean-Louis Excler, T. Anh Wartel & Sushant Sahastrabuddhe. (2020) Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study. EClinicalMedicine 27, pages 100540.
Crossref
Crossref
Francesca MicoliStefania P. Bjarnarson, Melissa ArcuriAudur Anna Aradottir PindGudbjorg J. MagnusdottirFrancesca NecchiRoberta Di BenedettoMartina Carducci, Fabiola SchiavoCarlo Giannelli, Ivan PisoniLaura B. MartinGiuseppe Del GiudiceCalman A. MacLennanRino Rappuoli, Ingileif JonsdottirAllan Saul. (2020)
Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM
197
conjugate vaccine
. Proceedings of the National Academy of Sciences 117:39, pages 24443-24449.
Crossref
Crossref
Pietro Mastroeni & Omar Rossi. (2020)
Antibodies and Protection in Systemic
Salmonella
Infections: Do We Still Have More Questions than Answers?
. Infection and Immunity 88:10.
Crossref
Crossref
Khalid Ali Syed, Tarun Saluja, Heeyoun Cho, Amber Hsiao, Hanif Shaikh, T Anh Wartel, Vittal Mogasale, Julia Lynch, Jerome H Kim, Jean-Louis Excler & Sushant Sahastrabuddhe. (2020) Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead. Clinical Infectious Diseases 71:Supplement_2, pages S141-S150.
Crossref
Crossref
A Duncan Steele, Megan E Carey, Supriya Kumar, Calman A MacLennan, Lyou-Fu Ma, Zoey Diaz & Anita K M Zaidi. (2020) Typhoid Conjugate Vaccines and Enteric Fever Control: Where to Next?. Clinical Infectious Diseases 71:Supplement_2, pages S185-S190.
Crossref
Crossref
Ritabrata Kundu, Ambrose Kumar Kandulna, Uma Nayak, Sanjay Kumar Jangid, T. Ramesh Babu, Rajesh Vukkala, Shrikant Sharma, Vimal Kant Goyal, Pavankumar Daultani, Ravindra Mittal & Pradip Patel. (2020) Immunogenicity and Safety of Typhoid Conjugate Vaccine in Healthy Indian Subjects: A Randomized, Active-controlled, Comparative Clinical Trial. Indian Pediatrics 57:7, pages 625-630.
Crossref
Crossref
Bernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, Rini Sekartini, Hindra Irawan Satari, Sri Rezeki Hadinegoro, Angga Wirahmadi, Mita Puspita, Rini Mulia Sari, Jae Seung Yang, Arijit Sil, Sushant Sahastrabuddhe & Novilia Sjafri Bachtiar. (2020) One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine. International Journal of Infectious Diseases 93, pages 102-107.
Crossref
Crossref
Eun Young Lee, Ju Yeon Park, Deok Ryun Kim, Manki Song, Sushant Sahastrabuddhe, Hun Kim, Yun Chon & Jae Seung Yang. (2020) Comparison of anti-Vi IgG responses between two clinical studies of typhoid Vi conjugate vaccines (Vi-DT vs Vi-TT). PLOS Neglected Tropical Diseases 14:3, pages e0008171.
Crossref
Crossref
Christopher Jones, So Jung An, Yeon Kyung Yoon, Sudeep Kothari, Sushant Sahastrabuddhe & Rodney Carbis. (2020) Spectroscopic characterisation of a series of Salmonella Typhi Vi-diphtheria toxoid glycoconjugate antigens differing in polysaccharide-protein ratio. Journal of Pharmaceutical and Biomedical Analysis 181, pages 113100.
Crossref
Crossref
VipinM Vashishtha & Ajay Kalra. (2020) The need & the issues related to new-generation typhoid conjugate vaccines in India. Indian Journal of Medical Research 151:1, pages 22.
Crossref
Crossref
Ralph Biemans, Francesca Micoli & Maria Rosaria Romano. 2020. Recent Trends in Carbohydrate Chemistry. Recent Trends in Carbohydrate Chemistry
285
313
.
Neil Ravenscroft, Martin Braun, Joerg Schneider, Anita M Dreyer, Michael Wetter, Micha A Haeuptle, Stefan Kemmler, Michael Steffen, Dominique Sirena, Stefan Herwig, Paula Carranza, Claire Jones, Andrew J Pollard, Michael Wacker & Michael Kowarik. (2019) Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate. Glycobiology 29:9, pages 669-680.
Crossref
Crossref
Krisztina Hitri, Michelle M. Kuttel, Gianluigi De Benedetto, Kay Lockyer, Fang Gao, Peter Hansal, Timothy R. Rudd, Emma Beamish, Sjoerd Rijpkema, Neil Ravenscroft & Barbara Bolgiano. (2019) O-acetylation of typhoid capsular polysaccharide confers polysaccharide rigidity and immunodominance by masking additional epitopes. Vaccine 37:29, pages 3866-3875.
Crossref
Crossref
Sayan Das, Rimi Chowdhury, Ananda Pal, Keinosuke Okamoto & Santasabuj Das. (2019) Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever. Immunobiology 224:3, pages 371-382.
Crossref
Crossref
Stephen P Luby. (2018)
Urban Slums: A Supportive Ecosystem for Typhoidal
Salmonellae
. The Journal of Infectious Diseases 218:suppl_4, pages S250-S254.
Crossref
Crossref
Antony R. Parker, Caroline Bradley, Stephen Harding, Silvia Sánchez-Ramón, Stephen Jolles & Sorena Kiani-Alikhan. (2018) Measurement and interpretation of Salmonella typhi Vi IgG antibodies for the assessment of adaptive immunity. Journal of Immunological Methods 459, pages 1-10.
Crossref
Crossref
Arturo Casadevall. (2018) Antibody-based vaccine strategies against intracellular pathogens. Current Opinion in Immunology 53, pages 74-80.
Crossref
Crossref
Yi-An Yang, Alexander Chong & Jeongmin Song. (2018) Why Is Eradicating Typhoid Fever So Challenging: Implications for Vaccine and Therapeutic Design. Vaccines 6:3, pages 45.
Crossref
Crossref
Cinzia Colombo, Olimpia Pitirollo & Luigi Lay. (2018) Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development. Molecules 23:7, pages 1712.
Crossref
Crossref
Vijayalaxmi V. Mogasale, Enusa Ramani, Vittal Mogasale, Ju Yeon Park & Thomas F. Wierzba. (2018) Estimating Typhoid Fever Risk Associated with Lack of Access to Safe Water: A Systematic Literature Review. Journal of Environmental and Public Health 2018, pages 1-14.
Crossref
Crossref
Maria Rosario Capeding, Samuel Teshome, Tarun Saluja, Khalid Ali Syed, Deok Ryun Kim, Ju Yeon Park, Jae Seung Yang, Yang Hee Kim, Jiwook Park, Sue-Kyoung Jo, Yun Chon, Sudeep Kothari, Seon-Young Yang, Dong Soo Ham, Ji Hwa Ryu, Hee-Seong Hwang, Ju-Hwan Mun, Julia A. Lynch, Jerome H. Kim, Hun Kim, Jean-Louis Excler & Sushant Sahastrabuddhe. (2018) Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children. Vaccine 36:26, pages 3794-3801.
Crossref
Crossref
Hyon Jin Jeon, Gi Deok Pak, Justin Im, Ellis Owusu-Dabo, Yaw Adu-Sarkodie, Amy Gassama Sow, Abdramane Bassiahi Soura, Nagla Gasmelseed, Karen H Keddy, Morten Bjerregaard-Andersen, Frank Konings, Abraham Aseffa, John A Crump, Yun Chon, Robert F Breiman, Se Eun Park, Ligia Maria Cruz Espinoza, Hye Jin Seo, Jürgen May, Christian G Meyer, Jason R Andrews, Ursula Panzner, Vera von Kalckreuth, Thomas F Wierzba, Raphaël Rakotozandrindrainy, Gordon Dougan, Myron M Levine, Joachim Hombach, Jerome H Kim, John D Clemens, Stephen Baker & Florian Marks. (2018) Determining the Best Immunization Strategy for Protecting African Children Against Invasive Salmonella Disease. Clinical Infectious Diseases.
Crossref
Crossref
Gao‐Lan Zhang & Xin‐Shan Ye. (2018) Synthetic Glycans and Glycomimetics: A Promising Alternative to Natural Polysaccharides. Chemistry – A European Journal 24:26, pages 6696-6704.
Crossref
Crossref
So Jung An, Puthupparampil V. Scaria, Beth Chen, Emma Barnafo, Olga Muratova, Charles Anderson, Lynn Lambert, Myung Hwa Chae, Jae Seung Yang & Patrick E. Duffy. (2018) Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever. Vaccine 36:21, pages 2978-2984.
Crossref
Crossref
Gao-Lan Zhang, Meng-Man Wei, Chengcheng Song, Yu-Feng Ma, Xiu-Jing Zheng, De-Cai Xiong & Xin-Shan Ye. (2018)
Chemical synthesis and biological evaluation of penta- to octa- saccharide fragments of Vi polysaccharide from
Salmonella typhi
. Organic Chemistry Frontiers 5:14, pages 2179-2188.
Crossref
Crossref
Christopher Jones. 2018. Carbohydrate-Based Vaccines: From Concept to Clinic. Carbohydrate-Based Vaccines: From Concept to Clinic
273
321
.
Myron M. Levine. 2018. Plotkin's Vaccines. Plotkin's Vaccines
1114
1144.e10
.
M. Arcuri, R. Di Benedetto, A. F. Cunningham, A. Saul, C. A. MacLennan & F. Micoli. (2017) The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi. PLOS ONE 12:12, pages e0189100.
Crossref
Crossref
Jenny A. Walldorf, Kashmira A. Date, Nandini Sreenivasan, Jennifer B. Harris & Terri B. Hyde. (2017) Lessons Learned from Emergency Response Vaccination Efforts for Cholera, Typhoid, Yellow Fever, and Ebola. Emerging Infectious Diseases 23:13.
Crossref
Crossref
M. Salman, F. St. Michael, A. Ali, A. Jabbar, C. Cairns, A.C. Hayes, M. Rahman, M. Iqbal, A. Haque & A.D. Cox. (2017) First characterization of immunogenic conjugates of Vi negative Salmonella Typhi O-specific polysaccharides with rEPA protein for vaccine development. Journal of Immunological Methods 450, pages 27-33.
Crossref
Crossref
James E. Meiring, Malick Gibani, Buddha Basnyat, Adwoa D. Bentsi-Enchill, John Clemens, Thomas C. Darton, Kashmira Date, Gordon Dougan, Denise Garrett, Bradford D. Gessner, Melita A. Gordon, Robert S. Heyderman, Joachim Hombach, Karen L. Kotloff, Myron M. Levine, Stephen P. Luby, Vadrevu Krishna Mohan, Anthony A. Marfin, Kim Mulholland, Kathleen Neuzil, Virginia E. Pitzer, Andrew J. Pollard, Firdausi Qadri, David Salisbury & Anita Zaidi. (2017) The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26–27 October 2016, Oxford, UK. Vaccine 35:38, pages 5081-5088.
Crossref
Crossref
Sayan Das, Rimi Chowdhury, Shubhamoy Ghosh & Santasabuj Das. (2017) A recombinant protein of Salmonella Typhi induces humoral and cell-mediated immune responses including memory responses. Vaccine 35:35, pages 4523-4531.
Crossref
Crossref
Raine Garrido, Jean Pierre Soubal, Leonid Torres, Ubel Ramírez & Vicente Vérez. (2017)
NMR line‐fitting quantification of polysaccharide
N‐
acylurea‐based modification in glycoconjugates of
Salmonella
Typhi Vi polysaccharide
. Magnetic Resonance in Chemistry 55:8, pages 720-723.
Crossref
Crossref
Xin-Xing Gu, Stanley A. Plotkin, Kathryn M. Edwards, Alessandro Sette, Kingston H. G. Mills, Ofer Levy, Andrea J. Sant, Annie Mo, William Alexander, Kristina T. Lu & Christopher E. Taylor. (2017) Waning Immunity and Microbial Vaccines—Workshop of the National Institute of Allergy and Infectious Diseases. Clinical and Vaccine Immunology 24:7.
Crossref
Crossref
Thomas C Darton, James E Meiring, Susan Tonks, Md Arifuzzaman Khan, Farhana Khanam, Mila Shakya, Deus Thindwa, Stephen Baker, Buddha Basnyat, John D Clemens, Gordon Dougan, Christiane Dolecek, Sarah J Dunstan, Melita A Gordon, Robert S Heyderman, Kathryn E Holt, Virginia E Pitzer, Firdausi Qadri, K Zaman & Andrew J Pollard. (2017) The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys. BMJ Open 7:6, pages e016283.
Crossref
Crossref
Marina Antillón, Joke Bilcke, A. David Paltiel & Virginia E. Pitzer. (2017) Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings. Vaccine 35:27, pages 3506-3514.
Crossref
Crossref
Stephen P. Luby. (2017) Clean water, clean hands or new vaccines?. Journal of Infection 74, pages S18-S22.
Crossref
Crossref
C. Giannelli, E. Cappelletti, R. Di Benedetto, F. Pippi, M. Arcuri, V. Di Cioccio, L.B. Martin, A. Saul & F. Micoli. (2017) Determination of free polysaccharide in Vi glycoconjugate vaccine against typhoid fever. Journal of Pharmaceutical and Biomedical Analysis 139, pages 143-147.
Crossref
Crossref
Farjana Khatun, Rachel J. Stephenson & Istvan Toth. (2017) An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity. Chemistry - A European Journal 23:18, pages 4233-4254.
Crossref
Crossref
R. H. Behrens & N. Prevatt. 2017. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations
225
237
.
Kashmira A. Date, Anna E. Newton, Felicita Medalla, Anna Blackstock, LaTonia Richardson, Andre McCullough, Eric D. Mintz & Barbara E. Mahon. (2016) Changing Patterns in Enteric Fever Incidence and Increasing Antibiotic Resistance of Enteric Fever Isolates in the United States, 2008–2012. Clinical Infectious Diseases 63:3, pages 322-329.
Crossref
Crossref
Mi Seon Jang, Sushant Sahastrabuddhe, Cheol-Heui Yun, Seung Hyun Han & Jae Seung Yang. (2016) Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method. Microbial Pathogenesis 97, pages 19-26.
Crossref
Crossref
Jacob John, Carola J. C. Van Aart & Nicholas C. Grassly. (2016) The Burden of Typhoid and Paratyphoid in India: Systematic Review and Meta-analysis. PLOS Neglected Tropical Diseases 10:4, pages e0004616.
Crossref
Crossref
A. Duncan Steele, Deborah C. Hay Burgess, Zoey Diaz, Megan E. Carey & Anita K. M. Zaidi. (2016) Challenges and Opportunities for Typhoid Fever Control: A Call for Coordinated Action. Clinical Infectious Diseases 62:suppl 1, pages S4-S8.
Crossref
Crossref
Stephen Baker, Joachim Hombach & Florian Marks. (2016) What Have We Learned From the Typhoid Fever Surveillance in Africa Program?. Clinical Infectious Diseases 62:suppl 1, pages S1-S3.
Crossref
Crossref
Peter J. Hart, Colette M. O’Shaughnessy, Matthew K. Siggins, Saeeda Bobat, Robert A. Kingsley, David A. Goulding, John A. Crump, Hugh Reyburn, Francesca Micoli, Gordon Dougan, Adam F. Cunningham & Calman A. MacLennan. (2016) Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen. PLOS ONE 11:1, pages e0145945.
Crossref
Crossref
Nareman F. Abu-Baker & Hussein Masoud. (2016) Synthesis, Characterization, and Immunological Properties of LPS-Based Vaccines Composed of O-Polysaccharides Conjugated with Recombinant Exoprotein A from <i>Pseudomonas aeruginosa</i>. Advances in Microbiology 06:04, pages 332-342.
Crossref
Crossref
Vittal Mogasale, Vijayalaxmi V. Mogasale, Enusa Ramani, Jung Seok Lee, Ju Yeon Park, Kang Sung Lee & Thomas F. Wierzba. (2016) Revisiting typhoid fever surveillance in low and middle income countries: lessons from systematic literature review of population-based longitudinal studies. BMC Infectious Diseases 16:1.
Crossref
Crossref
Neil Ravenscroft, Micha A Haeuptle, Michael Kowarik, Fabiana S Fernandez, Paula Carranza, Andreas Brunner, Michael Steffen, Michael Wetter, Sacha Keller, Corina Ruch & Michael Wacker. (2015)
Purification and characterization of a
Shigella
conjugate vaccine, produced by glycoengineering
Escherichia coli
. Glycobiology, pages cwv077.
Crossref
Crossref
Kashmira A. Date, Adwoa Bentsi-Enchill, Florian Marks & Kimberley Fox. (2015) Typhoid fever vaccination strategies. Vaccine 33, pages C55-C61.
Crossref
Crossref
Jason R. Andrews & Edward T. Ryan. (2015) Diagnostics for invasive Salmonella infections: Current challenges and future directions. Vaccine 33, pages C8-C15.
Crossref
Crossref
Andre Rebaza & Paul J. Lee. (2015) One More Shot for the Road: A Review and Update of Vaccinations for Pediatric International Travelers. Pediatric Annals 44:4.
Crossref
Crossref
N. Ravenscroft, P. Cescutti, M. Gavini, G. Stefanetti, C.A. MacLennan, L.B. Martin & F. Micoli. (2015) Structural analysis of the O-acetylated O-polysaccharide isolated from Salmonella paratyphi A and used for vaccine preparation. Carbohydrate Research 404, pages 108-116.
Crossref
Crossref
Jan Holmgren & Myron M. Levine. 2015. Mucosal Immunology. Mucosal Immunology
1047
1082
.
Belkis Romeu, Miriam Lastre, Laura Reyes, Elizabeth González, Yusnaby Borrero, Diandra Lescaille, Rocmira Pérez, Darzy Nuñez & Oliver Pérez. (2014) Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses. Vaccine 32:51, pages 6971-6978.
Crossref
Crossref
Chris Coward, Olivier Restif, Richard Dybowski, Andrew J. Grant, Duncan J. Maskell & Pietro Mastroeni. (2014) The Effects of Vaccination and Immunity on Bacterial Infection Dynamics In Vivo. PLoS Pathogens 10:9, pages e1004359.
Crossref
Crossref
Taufiqur R. Bhuiyan, Feroza K. Choudhury, Farhana Khanam, Amit Saha, Md. Abu Sayeed, Umme Salma, Firdausi Qadri, Anna Lundgren, Ann-Mari Svennerholm & David A. Sack. (2014) Response on letter by Arya et al.: “Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.”. Vaccine 32:32, pages 4014.
Crossref
Crossref
Shousun C. Szu, Kimi F.-Y. Lin, Steven Hunt, Chiayung Chu & Nguyen Duc Thinh. (2014) Phase I clinical trial of O-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine. Vaccine 32:22, pages 2618-2622.
Crossref
Crossref
Shousun C. Szu, Keith P. Klugman & Steven Hunt. (2014) Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children. Vaccine 32:20, pages 2359-2363.
Crossref
Crossref
N. Berens-Riha, M. Alberer & T. Löscher. (2014) ReiseimpfungenVaccinations for international travelers. Der Internist 55:3, pages 246-258.
Crossref
Crossref